Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Standard Biotools (LAB) Leases (2019 - 2025)

Standard Biotools (LAB) has disclosed Leases for 7 consecutive years, with $26.7 million as the latest value for Q4 2025.

  • Quarterly Leases rose 0.62% to $26.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.7 million through Dec 2025, up 0.62% year-over-year, with the annual reading at $26.7 million for FY2025, 0.62% up from the prior year.
  • Leases for Q4 2025 was $26.7 million at Standard Biotools, up from $23.5 million in the prior quarter.
  • The five-year high for Leases was $38.7 million in Q2 2021, with the low at $23.5 million in Q3 2025.
  • Average Leases over 5 years is $32.1 million, with a median of $32.6 million recorded in 2023.
  • The sharpest move saw Leases increased 4.33% in 2021, then dropped 22.51% in 2025.
  • Over 5 years, Leases stood at $37.1 million in 2021, then dropped by 8.72% to $33.9 million in 2022, then fell by 9.5% to $30.7 million in 2023, then fell by 13.36% to $26.6 million in 2024, then grew by 0.62% to $26.7 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $26.7 million, $23.5 million, and $24.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.